利用印度陆地品种开发高蛋白和矿物质的生物强化谷物
Mallela Venkata Nagesh Kumar1, Vittal Ramya1, Setaboyine Maheshwaramma1
1Professor Jayashankar Telangana State Agricultural University, Hyderabad, India.
Frontiers in nutrition
|October 25, 2023
概括
使用陆地品种的的遗传生物强化改善了蛋白质和铁等关键营养特征. 这项研究强调了传统品种对抗半干旱地区营养不良的潜力.
科学领域:
- 农业科学 农业科学
- 植物育种 植物育种
- 营养科学 营养科学
背景情况:
- 是数百万人的重要粮食和蛋白质来源,特别是在亚洲和撒哈拉以南非洲.
- 现代菜品种显示营养含量下降,需要遗传生物强化来解决营养不良问题.
- 的无质,抗氧化剂和低血糖指数特性增加了它的谷物价值.
研究的目的:
- 评估九个营养和质量参数的基因改进在基因型中.
- 利用陆地品种的有价值的等位基因来增强的营养特征.
- 为了识别高产,弹性基因型,改善营养成分组成.
主要方法:
- 开发了来自11个印度陆地品种的19种小麦基因型.
- 2017年至2022年使用单种子下降 (SSD) 方法提升基因型.
- 对九个营养和质量参数的评估:原蛋白,体外蛋白质消化能力 (IVPD),总铁 (Fe),总 (Zn),生物可用Fe (%),生物可用Zn (%),总,素和抗氧化活性.
主要成果:
- 在所有9个营养和质量参数中,在地种和基因型之间观察到显著的差异.
- 基因型PYPS 2和PYPS 13显示出最多的原蛋白和IVPD.
- 在几种基因型中记录了高水平的Fe,Zn,和抗氧化活性.
- 在特定的基因型中,SSD方法导致原蛋白,,抗氧化活性,Fe和素的显著改善.
结论:
- 土地品种是遗传生物强化的一个宝贵资源.
- 这种方法提供了一种低成本,环保的策略,以提高的营养供应.
- 通过使用陆地品种来改善的基因,可以提高半干旱热带地区的生产力和营养价值.
更多相关视频
相关概念视频
Plant Breeding and Biotechnology
19.0K
Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
19.0K
Transgenic Plants
7.3K
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
7.3K
Bioavailability: Overview
2.8K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.8K


